Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience

BACKGROUND: Some patients experience oligo-progression during androgen receptor targeted therapy (ARTT) treatments. This progression might not indicate a real systemic drug resistance, but a selective monoclonal resistance. With the aim to delay the start of new line treatments we treated oligo-prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Valeriani, Maurizio, Marinelli, Luca, Macrini, Serena, Reverberi, Chiara, Aschelter, Anna Maria, De Sanctis, Vitaliana, Marchetti, Paolo, Tronnolone, Lidia, Osti, Mattia Falchetto
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857348/
https://ncbi.nlm.nih.gov/pubmed/31727093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1414-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados